To determine if photodynamic therapy with verteporfin (Visudyne; CIBA Vision Corp, Duluth, GA) can improve the chance of stabilizing or improving vision (<8 letter loss) safely in patients with subfoveal choroidal neovascularization (CNV) caused by pathologic myopia.
Title
Photodynamic therapy of subfoveal choroidal neovascularization in pathologic myopia with verteporfin: 1-year results of a randomized clinical trial--VIP report no. 1
Published in
Ophthalmology
Volume
108
Issue
5
Pages
841-52
Date
2001
Publisher
Elsevier
ISSN
0161-6420
Record creation date
2011-02-16